Home     About SABCS     Press Releases     Media     Event Photos     Past Symposia     Satellite Symposia     Patient Advocates     FAQs     Contact Us



Registration           Hotel           Late Breaking Abstract Submission     Support & Exhibits     2014 Overview           Program           Travel & Transportation          

Quick Links
Career Development Forum Reg Form
SABCS 2013 Program Book pdf

Schedule at a Glance
 
Daily Schedule:
Tue. 12/9/2014
Wed. 12/10/2014
Thu. 12/11/2014
Fri. 12/12/2014
Sat. 12/13/2014
 
Poster Sessions:
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Poster Session 5
Poster Session 6
 
Poster Session OT1
Poster Session OT2
Poster Session OT3
 
Poster Discussions:
Poster Discussion 1
Poster Discussion 2
Poster Discussion 3
Poster Discussion 4
Poster Discussion 5
Poster Discussion 6
 

Program Schedule   >  Poster Sessions - Poster Discussion 2

Poster Discussion 2 
   
  Body Mass, Exercise, and Breast Cancer
PD2-1 Body mass index at diagnosis and breast cancer survival prognosis among clinical trial populations: Results from NSABP B-30, B-31, B-34, and B-38
Cecchini RS, Swain SM, Costantino JP, Rastogi P, Jeong J-H, Anderson SJ, Tang G, Geyer CE, Lembersky BC, Romond EH, Paterson AHG, Wolmark N. NSABP Operations and Biostatistical Centers, Pittsburgh, PA; University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA; Washington Cancer Institute, Washington, DC; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lucille Parker Markey Cancer Center University of Kentucky, Lexington, KY; Tom Baker Cancer Centre, Calgary, AB, Canada; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA.
PD2-2 Body mass index (BMI) and treatment outcome of breast cancer patients receiving neoadjuvant therapy (NACT)
Fontanella C, von Minckwitz G, Mergler B, Neven P, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Gerber B, Vanoppen M, Hanusch C, Hilfrich J, Huober J, Schneeweiss A, Paepke S, Jackisch C, Keyur M, Nekljudova V, Untch M, Loibl S. German Breast Group, Neu-Isenburg, Germany; University Hospital of Udine, Udine, Italy; Multidisciplinary Breast Centre, UZ Leuven, Belgium; Frauenklinik, St. Gertrauden Krankenhaus, Berlin, Germany; Universitäts-Frauenklinik, Magdeburg, Germany; Charitè - Universitätsmedizin Berlin, Berlin, Germany; Universitäts-Frauenklink, Kiel, Germany; Universitäts-Frauenklinik, Rostock, Germany; Rotkreuzklinikum München, Munich, Germany; Eilenriede Klinik Hannover, Hannover, Germany; Universitätsfrauenklinik Ulm, Ulm, Germany; Universitätsklinikum Heidelberg, Heidelberg, Germany; TU München, Munich, Germany; Klinikum Offenbach, Offenbach, Germany; HELIOS Klinikum Berlin Buch, Berlin, Germany.
PD2-3 High body mass index (BMI) and worse response to neoadjuvant chemotherapy (NACT) by breast cancer phenotype: Own data and external validation on German breast group (GBG) patients
Vanoppen M, Brouckaert O, Laenen A, Fontanella C, Wildiers H, Paridaens R, Leunen K, Amant F, Berteloot P, Smeets A, Loibl S, Floris G, Christiaens M-R, Vergote I, Neven P. University Hospitals, Leuven, Belgium; Interuniversity Center for Biostatistics and Statistical Bioinformatics, Leuven, Belgium; German Breast Group, Neu-Isenburg, Germany; University Hospital of Udine, Italy.
PD2-4 Association between body mass index change during neoadjuvant chemotherapy and pathologic complete response and overall survival in patients with inflammatory breast cancer or locally advanced non-inflammatory breast cancer
Kogawa T, Fouad TM, Wei C, El-Zein RA, Masuda H, Chavez-Mac-Gregor M, Melhem-Bertrandt A, Litton JK, Brewster AM, Alvarez RH, Hortobagyi GN, Vicente V, Ueno NT, Theriault RL. The University of Texas MD Anderson Cancer Center, Houston, TX.
PD2-5 Low carbohydrate dietary intervention improves insulin, hormonal levels and inflammatory markers in early stage, postmenopausal breast cancer survivors
Krie AK, Bohlen KN, Hu Y, Ageton C, Demuth H, Norfolk D, Kittelsrud J, Thomes R, Fahrendorf A, Muth J, Rojas-Espaillat LA, Davies GE. Avera Cancer Institute, Sioux Falls, SD; Avera Research Institute, Sioux Falls, SD; University of South Dakota, Sioux Falls, SD.
PD2-6 Exercise dose and type effects in breast cancer patients receiving chemotherapy: A randomized trial
Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Cook D, Jespersen D, Proulx C, Dolan LB, Forbes CC, Wooding E, Trinh L, Segal RJ. University of Alberta, Edmonton, AB, Canada; University of British Columbia, Vancouver, BC, Canada; Cross Cancer Institute, Edmonton, AB, Canada; British Columbia Cancer Agency, Vancouver, BC, Canada; Alberta Health Services, Calgary, AB, Canada; University of Ottawa Heart Institute, Ottawa, ON, Canada; The Ottawa Hospital Cancer Center, Ottawa, ON, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
PD2-7 Vigorous exercise across the lifespan and reduced risk of estrogen receptor negative breast cancer in African American women
Adams-Campbell LL, Palmer JR, Bethea T, Kipping-Ruane K, Rosenberg L. Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, DC; Slone Epidemiology Center at Boston University, Boston, MA.
   
 
Home | About SABCS | Press Releases | Media | Event Photos | Past Symposia | Satellite Symposia | Patient Advocates | FAQs | Contact Us
Registration | Hotel | Support & Exhibits | 2014 Overview | Program | Travel & Transportation

Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224 San Antonio, TX 78229 USA
Phone: 210-450-1550    Fax: 210-450-1560    Email: sabcs@uthscsa.edu
       line
Copyright © 2014 SABCS. All rights reserved. - Privacy Policy